SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $637,245 | -8.8% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $699,000 | -75.3% | 24,500 | -78.7% | 0.00% | -66.7% |
| Q2 2022 | $2,832,000 | +140.6% | 115,009 | +451.6% | 0.00% | +200.0% |
| Q1 2022 | $1,177,000 | -24.8% | 20,851 | -17.4% | 0.00% | 0.0% |
| Q4 2021 | $1,565,000 | -28.3% | 25,245 | -26.6% | 0.00% | -50.0% |
| Q3 2021 | $2,182,000 | -47.2% | 34,388 | -31.4% | 0.00% | -50.0% |
| Q2 2021 | $4,131,000 | +2.4% | 50,125 | -8.6% | 0.00% | 0.0% |
| Q1 2021 | $4,034,000 | +514.9% | 54,829 | +506.5% | 0.00% | +300.0% |
| Q4 2020 | $656,000 | – | 9,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
| Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
| M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
| Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
| Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
| EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
| Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
| Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
| Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |